NORTH BILLERICA, MA--(Marketwired - May 13, 2014) - SRS Medical, the leading provider of technology to improve men's bladder health, will showcase the company's key products at the 2014 AUA Annual Meeting, May 16-21, in Orlando, FL. The Spanner Prostatic Stent is the only stent for the prostate available in the U.S., and allows patients to return quickly to a high quality of life while providing unparalleled low infection rates and urethral complications. SRS Medical's Urocuff test delivers real-time status of a man's lower urinary tract function through a painless, five-minute procedure. In the US, benign prostatic hyperplasia (BPH) affects 70% of men over the age of 60, one of the fastest growing population segments in the US. SRS Medical's mission is to serve the medical needs of this challenging patient population.
"Our commitment to men's bladder health is evident in the innovative product portfolio we are now commercializing," explained Lee Brody, chief executive officer, SRS Medical. "While urologists and their patients have demanded innovations for decades, nothing has been as effective as our suite of products in terms of quality of life, ease of use, reduced patient morbidity, infection and disease management."
Physician's practices and hospital outpatient facilities alike can deploy SRS Medical's pioneering technologies. More than 200 Urologist offices nationwide have already implemented SRS' Spanner Prostatic Stent and Urocuff Test. The Spanner, an alternative to the Foley catheter, allows for normal urination and dramatically lower infection rates. The Urocuff Test identifies functional status of the patient's voiding capability in real-time, allowing physicians to choose the best treatment option, improving long-term prognosis for the patients urinary tract function.
SRS Medical's full product line will be available at AUA Booth #1969, May 16-21. To schedule a demo, please contact Chris Ernster at 800-345-5642 or firstname.lastname@example.org.